InvestorInvesting in private markets for over 30 years.
SV Dementia Discovery Fund (DDF)
The Dementia Discovery Fund (DDF) is a venture capital fund focused on investing in companies developing novel therapeutics for dementia, including Alzheimer's Disease. With offices in London and Boston, it has raised over $600 million to address this significant medical need.
Online destinations
Find SV Dementia Discovery Fund (DDF) online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
The Dementia Discovery Fund (DDF) is a venture capital fund managed by SV Health Investors, founded in 2015. It is based in London and Boston and focuses exclusively on investing in companies that develop or enable novel therapeutics for dementia, including Alzheimer's Disease. DDF has raised over $600 million for its investment strategy and aims to deliver measurable impact while generating financial returns. The fund invests across the full spectrum of company and asset stages, targeting innovative projects informed by cutting-edge science that can make a difference for dementia patients.
Focus
DDF invests across the full spectrum of company and asset stages, targeting innovative projects informed by cutting-edge science that can significantly impact dementia patients. The fund's mandate includes interrogating novel hypotheses and expanding the breadth of targets and mechanisms in development for dementia therapies, starting from target identification.
Support
DDF provides strategic support to its portfolio companies by leveraging its extensive network of pharmaceutical partners for collaborations and follow-on investments. The fund's focus on early-stage biotech ensures that it backs companies with deep scientific differentiation, enhancing their potential for success in the competitive landscape of dementia therapeutics.
Questions
What are DDF's investment criteria?
DDF exclusively invests in companies developing novel therapeutics for dementia, including Alzheimer's Disease. The fund targets early-stage projects across pre-seed, seed, seed-plus, and Series A stages, focusing on innovative solutions informed by cutting-edge science.
How can entrepreneurs apply for investment?
Entrepreneurs seeking investment from DDF are encouraged to contact the fund via email. The fund's registered office is located at 71 Kingsway, London, WC2B 6ST.
What makes DDF different from other venture capital firms?
DDF's unique focus on dementia therapeutics sets it apart from other venture capital firms. The fund leverages a strong network of pharmaceutical partners for strategic collaborations and follow-on investments, enhancing the potential for success of its portfolio companies.
What is DDF's geographic scope?
DDF has a global investment approach, with a particular focus on North America and Europe. This geographic diversity allows the fund to tap into a wide range of innovative projects and partnerships.
What is the fund size and check size range?
DDF has raised over $600 million across its funds, with specific check sizes varying based on the stage of investment and the needs of the portfolio companies. The fund's strategy allows for flexibility in supporting early-stage ventures.
What kind of post-investment involvement does DDF have?
DDF provides strategic support to its portfolio companies, leveraging its extensive network of pharmaceutical partners for collaborations and follow-on investments. The fund's focus on early-stage biotech ensures that it backs companies with deep scientific differentiation, enhancing their potential for success.
Check your startup’s fit
Check your startup’s fit with SV Dementia Discovery Fund (DDF)Similar investors
Organizations that do similar work to SV Dementia Discovery Fund (DDF).
Investor
InvestorInnovative investment strategies for exceptional long-term returns.
InvestorGlobal private investment firm with diverse strategies.
InvestorTransforming businesses for long-term success.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works